undefined
EUTM file information

018298184

ACCUMULUS SYNERGY


August 27, 2020

Trademark Summary

The trademark application ACCUMULUS SYNERGY was filed by Accumulus Synergy, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 4, 2020, and it was registered by office on January 13, 2021 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Change of name and address of the trademark registration was recorded on December 10, 2020. Appointment and Replacement of representative of the trademark registration was recorded on January 27, 2021.


Goods And Services

  • The mark was filed in class 9 with Downloadable computer software for aggregating, converting, processing and transferring health, medical and scientific data to a cloud platform enabling the exchange of data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations, global health regulators, and other government agencies.
  • The mark was filed in class 42 with following description of goods:
    1. Providing computer software platforms for centralized conversion, processing, storage and exchange of health, medical and scientific data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations, global health regulators, and other government agencies
    2. Design and development of application programming interfaces and computer software for database management and cloud services that enable the storage, conversion, processing, and exchange of health, medical and scientific data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations, global health regulators, and other government agencies
    3. Nondownloadable computer software for aggregating, converting, processing and transferring health, medical and scientific data to a cloud platform enabling the exchange of data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations, global health regulators, and other government agencies.